John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$175M |
| 2 |
Meta Platforms (Facebook)
META
|
+$163M |
| 3 |
ABMD
Abiomed Inc
ABMD
|
+$138M |
| 4 |
Constellation Brands
STZ
|
+$135M |
| 5 |
Johnson & Johnson
JNJ
|
+$132M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$173M |
| 2 |
Pfizer
PFE
|
+$159M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$136M |
| 4 |
Dominion Energy
D
|
+$133M |
| 5 |
eBay
EBAY
|
+$118M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.76% |
| 2 | Consumer Discretionary | 11% |
| 3 | Industrials | 10.42% |
| 4 | Healthcare | 9.63% |
| 5 | Financials | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2976
PUT
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.3B
| $284K | ﹤0.01% |
+5,200
| New | +$275K |
|
|
VAR
2977
PUT
DELISTED
Varian Medical Systems, Inc.
VAR
| $284K | ﹤0.01% |
2,500
+200
| +9% | +$23.9K |
|
2978
PUT
Leidos
LDOS
$17.4B
| $283K | ﹤0.01% |
+4,800
| New | +$299K |
|
|
FNGN
2979
DELISTED
Financial Engines, Inc.
FNGN
| $283K | ﹤0.01% |
6,300
-114,201
| -95% | -$4.72M |
|
2980
CALL
Tanger
SKT
$4.47B
| $282K | ﹤0.01% |
12,000
-24,700
| -67% | -$543K |
|
|
HDSN
2981
Hudson Technologies
HDSN
$232M
| $281K | ﹤0.01% |
+139,565
| New | +$452K |
|
2982
CALL
Vanguard Morningstar Total Stock Market ETF
VTI
$683B
| $281K | ﹤0.01% |
+2,000
| New | +$279K |
|
|
FLY
2983
DELISTED
Fly Leasing Limited
FLY
| $280K | ﹤0.01% |
19,837
-4,948
| -20% | -$68.3K |
|
2984
PUT
Illumina
ILMN
$33.7B
| $279K | ﹤0.01% |
1,028
-7,916
| -89% | -$2.01M |
|
|
BELFB
2985
Bel Fuse Inc Class B
BELFB
$3.58B
| $278K | ﹤0.01% |
+13,288
| New | +$269K |
|
2986
Prosperity Bancshares
PB
$8.74B
| $278K | ﹤0.01% |
+4,068
| New | +$297K |
|
2987
TriplePoint Venture Growth BDC
TPVG
$217M
| $278K | ﹤0.01% |
22,359
+7,005
| +46% | +$87.7K |
|
2988
PUT
KLA
KLAC
$237B
| $277K | ﹤0.01% |
27,000
-66,000
| -71% | -$718K |
|
|
EDN
2989
Edenor
EDN
$1.03B
| $276K | ﹤0.01% |
+8,500
| New | +$412K |
|
2990
World Acceptance Corp
WRLD
$887M
| $276K | ﹤0.01% |
2,488
-11,264
| -82% | -$1.23M |
|
|
SRRA
2991
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $276K | ﹤0.01% |
2,328
+1,212
| +109% | +$122K |
|
2992
CALL
Knight Transportation
KNX
$11.2B
| $275K | ﹤0.01% |
+7,200
| New | +$296K |
|
2993
PDS Biotechnology
PDSB
$12.1M
| $275K | ﹤0.01% |
13,372
+11,750
| +724% | +$245K |
|
2994
Utah Medical Products
UTMD
$228M
| $275K | ﹤0.01% |
2,501
-3,266
| -57% | -$341K |
|
2995
BioLife Solutions
BLFS
$1.82B
| $274K | ﹤0.01% |
23,995
+6,838
| +40% | +$62.3K |
|
2996
CALL
HF Sinclair
DINO
$16.9B
| $274K | ﹤0.01% |
4,000
-75,400
| -95% | -$5.02M |
|
|
2997
PUT
HF Sinclair
DINO
$16.9B
| $274K | ﹤0.01% |
4,000
-83,900
| -95% | -$5.59M |
|
2998
CALL
O'Reilly Automotive
ORLY
$73.4B
| $274K | ﹤0.01% |
15,000
-786,000
| -98% | -$13.7M |
|
2999
PUT
Under Armour
UAA
$2.31B
| $274K | ﹤0.01% |
12,200
-22,900
| -65% | -$452K |
|
|
UCTT
3000
PUT
Ultra Clean Holdings
UCTT
$3.3B
| $274K | ﹤0.01% |
16,500
-5,100
| -24% | -$89.5K |
|
Similar funds
John Overdeck's Q2 2018 Portfolio in Review
As of Q2 2018, John Overdeck held 3,907 positions worth $33.5B, up 12% from $30B the previous quarter. Its ten largest holdings account for 5.6% of the portfolio.
John Overdeck deployed $2.27B of net new capital in Q2 2018, opening 829 new positions and adding to 1,295 existing holdings. Its largest new stake was Alphabet (Google) Class A: 3,215,020 shares worth $182M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 13% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Booking.com, an estimated $173M trimmed.
- John Overdeck's largest Q2 2018 buy was Alphabet (Google) Class A: 3,215,020 shares worth $182M.
- John Overdeck added most to Abiomed Inc in Q2 2018, an estimated $138M increase.
- John Overdeck's biggest Q2 2018 reduction was Booking.com, cutting an estimated $173M.
- John Overdeck fully exited Pfizer in Q2 2018, selling an estimated $159M.
- John Overdeck's ten largest holdings make up 5.6% of its $33.5B portfolio in Q2 2018.
- John Overdeck opened 829 new positions and closed 662 in Q2 2018.
- John Overdeck's portfolio value rose 12% quarter-over-quarter to $33.5B.
Based on Two Sigma Investments's 13F filing for Q2 2018, filed 14 Aug 2018.